explore -WSS

explore

author：knowledge 2025-09-30 14:08:45 - browse：58387

illustration of one blue dna strand — Adobe

The Food and Drug Administration is convening a meeting of outside experts on Tuesday to review exa-cel, a CRISPR-based treatment for sickle cell disease made by Vertex Pharmaceuticals and CRISPR Therapeutics.

Tuesday’s meeting is set up a bit differently than most FDA advisory panels. The agency has not raised any concerns about exa-cel’s efficacy or safety, and there will not be a typical vote at the end of the day on whether the data from exa-cel’s pivotal clinical trial support an approval as a treatment for sickle cell disease.

Instead, the FDA is seeking input about the methods used by Vertex and CRISPR Therapeutics to evaluate the risk of inadvertently making unwanted changes to patients’ DNA — so-called off-target editing — when exa-cel is administered.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

WSS

Dogs on Prozac: What pet anti

Stroke rates rising, especially in working

Beyond aggravation: Constipation is an American epidemic

Bird flu makes raw milk dangerous to consume, mouse study finds

Unmasking the 'centricity' illusion in clinical trials

Element Biosciences CEO lays out genome sequencing strategy

hotspot

explore

focus

Medicare details structure of new drug price negotiation program

Should insurance cover cosmetic surgery?

ChatGPT in medicine: STAT answers readers' burning questions

J&J reports mixed data on next

Affirmative action in medical school literally saved lives

Melinda French Gates resigns from Gates Foundation

Activists slam private health insurers over coverage restrictions

U.S. death rates show how politics are affecting public health

Psychedelics group wrestles with new pharma identity

UnitedHealth financials solid despite Change Healthcare cyberattack

hotspot

Health care needs a new profession: neuroimaging counseling

Stroke rates rising, especially in working

MultiPlan and major insurers sued for alleged medical price

Why some fertility treatments produce more boy babies

J&J reports mixed data on next

Orangutan used medicinal plant to treat wound, first time ever seen

focus

focus

Wikipedia

knowledge